GO
Loading...

Enter multiple symbols separated by commas

Mergers and Acquisitions Acquisitions

More

  • LONDON, July 29- British investor Neil Woodford is backing a start-up biopharmaceutical firm whose first venture will be to launch clinical trials of three drugs developed by Novartis. It said has raised $119 million from Woodford Investment and Invesco Perpetual among others, and has acquired drug programmes from Novartis for the treatment of brittle bone...

  • BRUSSELS— Belgium's chemical group Solvay has announced it will buy U.S.-based Cytec for $5.5 billion, making it the second biggest company in the aerospace composite materials market. In Wednesday's announcement, CEO Jean-Pierre Clamadieu said that the proposed acquisition "marks a major step change in Solvay's portfolio upgrade" to expand into the...

  • FRANKFURT, July 28- German drugs packaging firm Gerresheimer has agreed to buy U.S. plastic vial maker Centor for $725 million in cash, giving it a leading position in the world's biggest drugs market and lifting its shares to an all-time high. Shares in Gerresheimer jumped more than 15 percent to 65.33 euros, valuing the company at 2.05 billion euros.

  • Reynolds American beats 2Q profit forecasts Tuesday, 28 Jul 2015 | 7:34 AM ET

    WINSTON SALEM, N.C.— Reynolds American reported a surge in second-quarter profit with cigarette prices and volume rising. Earnings, adjusted for non-recurring gains, came to $1.02 per share, which was still 8 cents better than analysts had expected, according to a poll by Zacks Investment Research. It recently closed on a $25 billion takeover of Newport seller...

  • Merck& Co.' s second-quarter profit plunged by two-thirds, hammered by the sale of its consumer business, unfavorable currency exchange rates, lower sales of some key drugs and hefty one-time charges. The world's fifth-biggest drugmaker by revenue beat modest Wall Street expectations and raised its full-year profit forecast by a dime per share, but shares...

  • Gerresheimer buys U.S. plastic vials maker Centor Tuesday, 28 Jul 2015 | 6:44 AM ET

    FRANKFURT, July 28- German drugs packaging firm Gerresheimer has agreed to buy U.S. plastic vial maker Centor for $725 million in cash, giving it a leading position in the world's biggest drugs market and lifting its shares to an all-time high. Shares in Gerresheimer jumped more than 15 percent to 65.33 euros, valuing the company at 2.05 billion euros.

  • July 28- Hikma Pharmaceuticals Plc. *Acquires Roxane Laboratories, transforming its position in us generics market. *Under terms of acquisition, on closing of transaction Hikma will pay gross consideration of $1.18 billion in cash and will issue 40 million new Hikma shares to Boehringer.

  • NEW YORK, July 27- Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger. As head of Actavis, he then sealed a $66 billion purchase of Botox-maker Allergan, beating out rival suitor Valeant...

  • Comcast, Discovery renew distribution agreement Monday, 27 Jul 2015 | 3:17 PM ET

    Under the deal, Comcast's Xfinity TV customers in the United States will get Discovery's 12 U.S. networks, allowing them to access both past and current Discovery content on mobile devices for the first time. Discovery and Comcast had previously clashed over Comcast's scuttled deal to acquire Time Warner Cable Inc earlier this year. Comcast had accused...

  • Allergan to own 10% stake in Teva Monday, 27 Jul 2015 | 3:14 PM ET
    Allergan to own 10% stake in Teva

    CNBC's Meg Tirrell reports Teva is buying Allergan's generic drugs unit, giving Allergan a 10 percent stake in Teva.

  • NEW YORK, July 27- Allergan CEO Brent Saunders said on Monday the company will use the $36 billion it nets from the sale of its generics business to Teva for more deals, including large, "transformational" merger opportunities. Saunders, who led the $66 billion combination of Actavis and Allergan that closed only a few months ago, told investors that it would use the...

  • Teva to acquire Allergan generics unit Monday, 27 Jul 2015 | 10:08 AM ET
    Teva to acquire Allergan generics unit

    Shares of Allergan and Teva are higher after the announcement Teva will acquire Allergan's generics unit for $40.5 billion, with CNBC's Meg Tirrell.

  • TEL AVIV, July 27- Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms. It also will allow Dublin- based Allergan, the third-largest generic drugmaker in the United States, to focus on branded drugs...

  • The operator from northwest Spain was bought by Zegona, formed by Eamonn O'Hare and Robert Samuelson, who helped build up and then sell Virgin Media in 2013.. The deal is the fourth big telecoms deal in Spain in the last 18 months, after Vodafone bought Ono, Orange snapped up Jazztel and Euskaltel last week agreed an offer for R Cable. It will fund the acquisition with...

  • JERUSALEM— Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin- based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company. Statements from both companies say the deal will see Allergan receive $33.75 billion in cash and shares...

  • Zegona buys Spain's Telecable for 640 mln euros Monday, 27 Jul 2015 | 2:39 AM ET

    LONDON, July 27- Zegona, the company set up by the former Virgin Media finance director Eamonn O'Hare, said on Monday it had bought Spanish cable operator Telecable for an enterprise value of 640 million euros. Zegona, set up to buy and run businesses in the European technology, media and telecoms sector, said it would fund the acquisition with a combination of 251...

  • SYDNEY, July 27- Billionaire Gina Rinehart has bought a West Australian cattle station, further expanding into the country's farm sector with a deal that positions the mining magnate to profit from a recent Australian live cattle-export agreement with China. Rinehart, the richest person in Australia, completed the purchase of the Fossil Downs cattle station...

  • TEL AVIV, July 26- After months of sparring in a hostile takeover bid for rival Mylan NV, Teva Pharmaceutical's move to buy Allergan Plc's generic drug business instead could be a smoother ride that will bring bigger returns, faster. Israel- based Teva, the world's largest generic drugmaker, is in advanced talks to buy Allergan's generic drugs unit for between $40-...

  • BERLIN— Frankfurt stock exchange operator Deutsche Boerse AG says it is buying foreign exchange trading platform 360 T for 725 million euros. Deutsche Boerse said Sunday that it plans to finance the acquisition of 360 T using a combination of debt and equity, a route aimed at minimizing any impact on its credit rating. It says 360 T, which is based in Frankfurt and...

  • FRANKFURT, July 26- Deutsche Boerse is buying German-based foreign exchange trading platform 360 T for 725 million euros, the Frankfurt- based stock market operator said on Sunday. 360 T is one of a handful of multi-bank, multi-user platforms which have revolutionized foreign exchange trading over the past decade and Deutsche Boerse beat U.S. commodities and...